Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

AXDX

Accelerate Diagnostics (AXDX)

Accelerate Diagnostics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:AXDX
FechaHoraFuenteTítuloSímboloCompañía
05/12/202416:13Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:AXDXAccelerate Diagnostics Inc
03/12/202419:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXDXAccelerate Diagnostics Inc
14/11/202414:24Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:AXDXAccelerate Diagnostics Inc
07/11/202415:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXDXAccelerate Diagnostics Inc
07/11/202415:05PR Newswire (US)Accelerate Diagnostics Reports Third Quarter 2024 Financial ResultsNASDAQ:AXDXAccelerate Diagnostics Inc
25/10/202415:30PR Newswire (US)Accelerate Diagnostics Scheduled Call to Review 2024 Third Quarter ResultsNASDAQ:AXDXAccelerate Diagnostics Inc
30/09/202408:15PR Newswire (US)Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc™ SystemNASDAQ:AXDXAccelerate Diagnostics Inc
08/08/202416:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AXDXAccelerate Diagnostics Inc
08/08/202415:05PR Newswire (US)Accelerate Diagnostics Reports Second Quarter 2024 Financial ResultsNASDAQ:AXDXAccelerate Diagnostics Inc
08/08/202415:00PR Newswire (US)Accelerate Diagnostics Announces a Successful Completion of its WAVE™ Pre-Clinical TrialNASDAQ:AXDXAccelerate Diagnostics Inc
08/08/202410:09PR Newswire (US)Accelerate Diagnostics Scheduled Call to Review 2024 Second Quarter ResultsNASDAQ:AXDXAccelerate Diagnostics Inc
23/05/202418:17Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:AXDXAccelerate Diagnostics Inc
10/05/202416:24Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:AXDXAccelerate Diagnostics Inc
08/05/202415:42PR Newswire (US)Accelerate Diagnostics Reports Preliminary First Quarter 2024 Financial ResultsNASDAQ:AXDXAccelerate Diagnostics Inc
02/05/202408:30PR Newswire (US)Accelerate Diagnostics Scheduled Call to Review 2024 First Quarter Results.NASDAQ:AXDXAccelerate Diagnostics Inc
28/03/202415:05PR Newswire (US)Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial ResultsNASDAQ:AXDXAccelerate Diagnostics Inc
07/03/202408:30PR Newswire (US)Accelerate Diagnostics Scheduled Call to Review 2023 Fourth Quarter and Full Year Results.NASDAQ:AXDXAccelerate Diagnostics Inc
05/03/202414:59Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:AXDXAccelerate Diagnostics Inc
22/01/202420:59Edgar (US Regulatory)Form 424B1 - Prospectus [Rule 424(b)(1)]NASDAQ:AXDXAccelerate Diagnostics Inc
21/01/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AXDXAccelerate Diagnostics Inc
19/01/202408:20PR Newswire (US)Accelerate Diagnostics Announces Pricing of Approximately $15 Million Public Offering and Private PlacementNASDAQ:AXDXAccelerate Diagnostics Inc
18/01/202406:19Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:AXDXAccelerate Diagnostics Inc
16/01/202406:45PR Newswire (US)Accelerate Diagnostics Announces Launch of Proposed Public OfferingNASDAQ:AXDXAccelerate Diagnostics Inc
07/01/202419:00PR Newswire (US)Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2023 ResultsNASDAQ:AXDXAccelerate Diagnostics Inc
13/12/202316:30Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:AXDXAccelerate Diagnostics Inc
27/11/202308:15PR Newswire (US)Accelerate Diagnostics Announces Collaboration for the Use of the Arc™ System in Combination With Bruker´s MALDI Biotyper®NASDAQ:AXDXAccelerate Diagnostics Inc
09/11/202315:05PR Newswire (US)Accelerate Diagnostics Reports Third Quarter 2023 ResultsNASDAQ:AXDXAccelerate Diagnostics Inc
30/10/202308:30PR Newswire (US)Accelerate Diagnostics Scheduled Call to Review 2023 Third Quarter Results.NASDAQ:AXDXAccelerate Diagnostics Inc
10/08/202315:05PR Newswire (US)Accelerate Diagnostics Reports Second Quarter 2023 Financial ResultsNASDAQ:AXDXAccelerate Diagnostics Inc
27/07/202308:30PR Newswire (US)Accelerate Diagnostics Scheduled Call to Review 2023 Second Quarter ResultsNASDAQ:AXDXAccelerate Diagnostics Inc
 Showing the most relevant articles for your search:NASDAQ:AXDX

Su Consulta Reciente

Delayed Upgrade Clock